We are live on ! Find out more
EGRX

Eagle Pharmaceuticals, Inc.
EGRX

Delisted

EGRX was delisted on the 2nd of October, 2024.

Back to rankings

28 hedge funds and large institutions have $24.4M invested in Eagle Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 28 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
+28
Holders Change %
–
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$5.43M
2
DM
Deerfield Management
New York
+$3.86M
3
PWAM
Park West Asset Management
California
+$2.84M
4
WSA
Wall Street Associates
California
+$2.72M
5
JP Morgan Chase
JP Morgan Chase
New York
+$2.41M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
1
Cormorant Asset Management
Massachusetts
$5.1M +$5.43M +400,000 New
DM
2
Deerfield Management
New York
$3.63M +$3.86M +284,653 New
PWAM
3
Park West Asset Management
California
$2.67M +$2.84M +209,200 New
WSA
4
Wall Street Associates
California
$2.55M +$2.72M +200,000 New
JP Morgan Chase
5
JP Morgan Chase
New York
$2.27M +$2.41M +177,650 New
Jennison Associates
6
Jennison Associates
New York
$1.97M +$2.1M +154,534 New
Allianz Asset Management
7
Allianz Asset Management
Germany
$1.61M +$1.71M +125,940 New
FCM
8
Farallon Capital Management
California
$1.27M +$1.36M +100,000 New
BFA
9
BlackRock Fund Advisors
California
$1M +$1.07M +78,665 New
BIT
10
BlackRock Institutional Trust
California
$364K +$387K +28,510 New
SCA
11
SAC Capital Advisors
Connecticut
$348K +$370K +27,288 New
Morgan Stanley
12
Morgan Stanley
New York
$291K +$309K +22,798 New
State Street
13
State Street
Massachusetts
$271K +$289K +21,290 New
Geode Capital Management
14
Geode Capital Management
Massachusetts
$175K +$187K +13,770 New
Millennium Management
15
Millennium Management
New York
$164K +$175K +12,900 New
BPC
16
Banque Pictet & Cie
Switzerland
$147K +$157K +11,557 New
NFA
17
Nationwide Fund Advisors
Ohio
$138K +$147K +10,834 New
FAAS
18
First Allied Advisory Services
California
$134K +$144K +10,600 New
BIM
19
BlackRock Investment Management
Delaware
$110K +$117K +8,639 New
California State Teachers Retirement System (CalSTRS)
20
California State Teachers Retirement System (CalSTRS)
California
$78K +$82.8K +6,100 New
TA
21
Teachers Advisors
New York
$43K +$46.2K +3,400 New
BA
22
BlackRock Advisors
Delaware
$17K +$18.5K +1,362 New
BRWM
23
B. Riley Wealth Management
Tennessee
$13K +$13.6K +1,000 New
Wells Fargo
24
Wells Fargo
California
$10K +$10.9K +800 New
Deutsche Bank
25
Deutsche Bank
Germany
$9K +$11K +809 New
1
2

EGRX Hedge Fund Activity: Q1 2014 in Review

28 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Eagle Pharmaceuticals, Inc. (EGRX) for Q1 2014, worth a combined $24.4M.

Buyers outnumbered sellers: 28 funds opened new EGRX positions and 0 closed out — a net gain of 28 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $5.43M.

  • 28 institutional investors held Eagle Pharmaceuticals, Inc. (EGRX) as of Q1 2014, up from 0 in Q4 2013.
  • Funds reported $24.4M of Eagle Pharmaceuticals, Inc. stock for Q1 2014.
  • 28 funds opened new Eagle Pharmaceuticals, Inc. positions in Q1 2014 and 0 closed out, a net change of +28 holders.
  • The largest Eagle Pharmaceuticals, Inc. buyer in Q1 2014 was Cormorant Asset Management, an estimated $5.43M added.

Based on aggregated 13F filings for Q1 2014.